alexa Abstract | Studies On Shankha Bhasma - II Comparison Of Antacid Activity Of Marketed Shankha Bhasma With Chewable Antacid Tablet

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication Open Access


In the present study, antacid activity of two marketed Shankha bhasma formulations was compared with a chewable antacid tablet. The activity was studied on the basis of acid neutralization capacity, Rosset-Rice test and Reheis test. All the products pass the Preliminary Antacid Test U.S.P. The acid neutralization capacity of the chewable tablet is significantly greater than the bhasmas. Bhasma (300 mg.) causes the initial pH to rise slightly above 5.0 and may cause acid rebound effect, whereas, the chewable tablet has slower rate of reaction confirmed by Reheis test. Bhasmas failed to raise pH to 3.0 in Reheis test. Thus the unitary dose for a marketed bhasma as an antacid is 300 mg was confirmed after its in vitro testing.

To read the full article Peer-reviewed Article PDF image

Author(s): Shubhangi Bagade H M Kadam SS Kadam A R Paradkar

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us